Welcome to our dedicated page for Argan SEC filings (Ticker: AGX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Argan Inc’s contract backlog or spotting cost-overrun warnings means sifting through hundreds of EPC disclosures. Each 10-K details percentage-of-completion accounting, while every 8-K can signal a newly awarded gas-fired or renewable project. The problem? These filings are dense and highly technical.
Stock Titan’s AI-powered summaries turn that challenge into a two-minute read. We monitor EDGAR around the clock, surface key data as soon as a document posts, and translate accounting jargon into plain language. Whether you need the latest Argan Inc quarterly earnings report 10-Q filing to gauge segment margins or want real-time alerts on Form 4 insider moves, you’ll find it here—already distilled and cross-referenced.
- Argan Inc insider trading Form 4 transactions—track executive buys and sells within minutes.
- Argan Inc quarterly earnings report 10-Q filing—see segment revenue and backlog updates.
- Argan Inc Form 4 insider transactions real-time—receive instant alerts on material moves.
- Argan Inc SEC filings explained simply—our AI distills complex EPC disclosures.
- Argan Inc earnings report filing analysis—compare contract margins quarter over quarter.
- understanding Argan Inc SEC documents with AI—skip jargon, keep the insight.
- Argan Inc executive stock transactions Form 4—evaluate alignment of management incentives.
- Argan Inc annual report 10-K simplified—find risk factors on fixed-price contracts fast.
- Argan Inc proxy statement executive compensation—review pay tied to project milestones.
- Argan Inc 8-K material events explained—know when new EPC awards hit the books.
You can also download original PDFs, compare historical 10-Qs, and export tables for modeling—without leaving this page. From backlog disclosures to cash-flow swings, our expert analysis highlights what moves the stock so you can make informed decisions sooner.
Form 4 filing overview: On June 17, 2025, Argan, Inc. (AGX) director John R. Jeffrey Jr. was granted 530 time-based restricted stock units (RSUs) at a conversion price of $0. The RSUs will vest in full on April 17, 2026.
After the grant, the director’s aggregate derivative holdings tied to AGX common stock increased to 3,947 RSUs. No common shares were bought or sold on the open market, so the transaction has no direct cash impact on the company. This appears to be a routine equity-compensation award intended to further align the director’s incentives with shareholder interests.
Argan, Inc. (AGX) – Form 4 insider filing:
Director Lisa Larroque filed a Form 4 on 20 June 2025 disclosing the award of 530 Time-Based Restricted Stock Units (TRSUs) granted on 17 June 2025. Each TRSU converts into one share of AGX common stock at no cost and will vest fully on 17 April 2026.
The filing shows no open-market purchases or sales; it is strictly an equity incentive grant. Following the transaction, the director’s derivative holdings linked to common stock increased to 1,225 units, all held directly.
The award is part of routine director compensation, adds only a modest potential dilution upon settlement, and does not alter Argan’s capital structure or control.
FAQ
What is the current stock price of Argan (AGX)?
What is the market cap of Argan (AGX)?
